OXB and Bristol Myers Squibb (BMS) are expanding a partnership regarding manufacture and supply of lentiviral vectors for BMS ...

The latest OXB agreement will help advance the company’s CAR-T therapies and provide a “reliable, scalable manufacturing ...

Pfizer, Eli Lilly, Novartis, Bristol Myers Squibb and AstraZeneca are all ramping up the use of AI, but drug discovery is not the primary success story—yet.

Oxford, UK – 4 February 2026: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces ...

Neurocrine Biosciences, Inc. ( NBIX) Q4 2025 Earnings Call February 11, 2026 4:30 PM EST ...

Large drugmakers once had more room to absorb failure, both financially and reputationally | Large drugmakers are facing tighter constraints than in the past, as financial, scientific and reputational ...

The requirement to manually perform regular checks and balances on enterprise procurement has often been viewed as slowing the speed of business and limiting corporate agility.

Bristol Myers stock is volatile ahead of earnings as investors weighed its expanded OXB manufacturing deal and recent bullish ...

Drug developers integrate AI capabilities as a potentially transformative strategy to combat patent cliff losses.

India's Budget 2026 brings groundbreaking changes to the auto industry, focusing on battery cost reductions, enhanced ...

A senior PMDA official associated with the project said that only a limited number of bids were received earlier, leading the ...

Wanxiang A123 Systems Corp. unveiled a next-generation safety solution at its "Gathering Stars, Smart Storage Future" event, introducing the Star Series semi-solid-state battery cells and Star River ...